Wilson Kirkland A, Han Yong, Zhang Miaoqi, Hess Jeremy P, Chapman Kimberly A, Cline Gary W, Tochtrop Gregory P, Brunengraber Henri, Zhang Guo-Fang
Department of Nutrition, Case Western Reserve University, Cleveland, Ohio.
Department of Chemistry, Case Western Reserve University, Cleveland, Ohio.
Am J Physiol Endocrinol Metab. 2017 Oct 1;313(4):E413-E428. doi: 10.1152/ajpendo.00105.2017. Epub 2017 Jun 20.
Propionate, 3-hydroxypropionate (3HP), methylcitrate, related compounds, and ammonium accumulate in body fluids of patients with disorders of propionyl-CoA metabolism, such as propionic acidemia. Although liver transplantation alleviates hyperammonemia, high concentrations of propionate, 3HP, and methylcitrate persist in body fluids. We hypothesized that conserved metabolic perturbations occurring in transplanted patients result from the simultaneous presence of propionate and 3HP in body fluids. We investigated the inter-relations of propionate and 3HP metabolism in perfused livers from normal rats using metabolomic and stable isotopic technologies. In the presence of propionate, 3HP, or both, we observed the following metabolic perturbations. First, the citric acid cycle (CAC) is overloaded but does not provide sufficient reducing equivalents to the respiratory chain to maintain the homeostasis of adenine nucleotides. Second, there is major CoA trapping in the propionyl-CoA pathway and a tripling of liver total CoA within 1 h. Third, liver proteolysis is stimulated. Fourth, propionate inhibits the conversion of 3HP to acetyl-CoA and its oxidation in the CAC. Fifth, some propionate and some 3HP are converted to nephrotoxic maleate by different processes. Our data have implications for the clinical management of propionic acidemia. They also emphasize the perturbations of the liver intermediary metabolism induced by supraphysiological, i.e., millimolar, concentrations of labeled propionate used to trace the intermediary metabolism, in particular, inhibition of CAC flux and major decreases in the [ATP]/[ADP] and [ATP]/[AMP] ratios.
丙酸、3-羟基丙酸(3HP)、甲基柠檬酸、相关化合物以及铵会在患有丙酰辅酶A代谢紊乱(如丙酸血症)的患者体液中蓄积。尽管肝移植可缓解高氨血症,但体液中仍持续存在高浓度的丙酸、3HP和甲基柠檬酸。我们推测,移植患者体内持续存在的代谢紊乱是由于体液中同时存在丙酸和3HP所致。我们使用代谢组学和稳定同位素技术研究了正常大鼠灌注肝脏中丙酸和3HP代谢的相互关系。在存在丙酸、3HP或两者的情况下,我们观察到以下代谢紊乱。首先,柠檬酸循环(CAC)过载,但无法为呼吸链提供足够的还原当量以维持腺嘌呤核苷酸的稳态。其次,丙酰辅酶A途径中存在大量辅酶A捕获,且肝脏总辅酶A在1小时内增加两倍。第三,肝脏蛋白水解受到刺激。第四,丙酸抑制3HP转化为乙酰辅酶A及其在CAC中的氧化。第五,一些丙酸和一些3HP通过不同过程转化为具有肾毒性的马来酸。我们的数据对丙酸血症的临床管理具有启示意义。它们还强调了超生理浓度(即毫摩尔浓度)的标记丙酸用于追踪中间代谢时所引起的肝脏中间代谢紊乱,特别是对CAC通量的抑制以及[ATP]/[ADP]和[ATP]/[AMP]比值的大幅下降。